Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Eligibility for sotagliflozin in a real-world heart failure population based on the SOLOIST-WHF trial enrolment criteria: data from the Swedish heart failure registry.
Becher PM, Savarese G, Benson L, Dahlström U, Karlström P, Mol PGM, Metra M, Bhatt DL, Pitt B, Lund LH. Becher PM, et al. Among authors: mol pgm. Eur Heart J Cardiovasc Pharmacother. 2023 Jun 2;9(4):343-352. doi: 10.1093/ehjcvp/pvad012. Eur Heart J Cardiovasc Pharmacother. 2023. PMID: 36718512
Eligibility for vericiguat in a real-world heart failure population according to trial, guideline and label criteria: Data from the Swedish Heart Failure Registry.
Nguyen NV, Lindberg F, Benson L, Ferrannini G, Imbalzano E, Mol PGM, Dahlström U, Rosano GMC, Ezekowitz J, Butler J, Lund LH, Savarese G. Nguyen NV, et al. Among authors: mol pgm. Eur J Heart Fail. 2023 Aug;25(8):1418-1428. doi: 10.1002/ejhf.2939. Epub 2023 Jun 29. Eur J Heart Fail. 2023. PMID: 37323078 Free article.
Safety of continuing mineralocorticoid receptor antagonist treatment in patients with heart failure with reduced ejection fraction and severe kidney disease: Data from Swedish Heart Failure Registry.
Guidetti F, Lund LH, Benson L, Hage C, Musella F, Stolfo D, Mol PGM, Flammer AJ, Ruschitzka F, Dahlstrom U, Rosano GMC, Braun OÖ, Savarese G. Guidetti F, et al. Among authors: mol pgm. Eur J Heart Fail. 2023 Dec;25(12):2164-2173. doi: 10.1002/ejhf.3049. Epub 2023 Oct 18. Eur J Heart Fail. 2023. PMID: 37795642 Free article.
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes: data from the Swedish Heart Failure and Swedish National Diabetes Registries.
Wallner M, Biber ME, Stolfo D, Sinagra G, Benson L, Dahlström U, Gudbjörnsdottir S, Cosentino F, Mol PGM, Rosano GMC, Butler J, Metra M, Lund LH, Ferrannini G, Savarese G. Wallner M, et al. Among authors: mol pgm. Eur Heart J Cardiovasc Pharmacother. 2024 Jul 16;10(4):296-306. doi: 10.1093/ehjcvp/pvae026. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38632048 Free PMC article.
Monoclonal antibody biosimilars for cancer treatment.
Broer LN, Knapen DG, de Groot DA, Mol PGM, Kosterink JGW, de Vries EGE, Lub-de Hooge MN. Broer LN, et al. Among authors: mol pgm. iScience. 2024 May 24;27(6):110115. doi: 10.1016/j.isci.2024.110115. eCollection 2024 Jun 21. iScience. 2024. PMID: 38974466 Free PMC article. Review.
Sex differences in the efficacy of angiotensin receptor blockers on kidney and cardiovascular outcomes among individuals with type 2 diabetes and diabetic kidney disease: post hoc analyses of the RENAAL and IDNT trials.
de Vries ST, Pena MJ, Tye SC, Peters SAE, van Raalte DH, Arnott C, Voors AA, Mol PGM, Denig P, Heerspink HJL. de Vries ST, et al. Among authors: mol pgm. Diabetologia. 2024 Dec 10. doi: 10.1007/s00125-024-06325-y. Online ahead of print. Diabetologia. 2024. PMID: 39656268
Real-World Evidence to Support EU Regulatory Decision Making-Results From a Pilot of Regulatory Use Cases.
Prilla S, Groeneveld S, Pacurariu A, Restrepo-Méndez MC, Verpillat P, Torre C, Gartner C, Mol PGM, Naumann-Winter F, Breen KC, Gault N, Gross-Martirosyan L, Benchetrit S, Aylward B, Stoyanova-Beninska V, O'Donovan M, Straus S, Kjaer J, Arlett P. Prilla S, et al. Among authors: mol pgm. Clin Pharmacol Ther. 2024 Nov;116(5):1188-1197. doi: 10.1002/cpt.3355. Epub 2024 Jul 4. Clin Pharmacol Ther. 2024. PMID: 38962830 Review.
103 results